Intracellular Ca^<2+> regulation in the myocardium with ryanodine receptor type 2(+/-) heterozygous mouse
兰尼定受体2型(/-)杂合小鼠心肌细胞内Ca^<2>调节
基本信息
- 批准号:13670048
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We produced knockout mouse with ryanodine receptor type 2 (RyR-2(+/-)) and explored the cardiac functions of the heart. In Langenforff perfusion, we could not detect any significant changes of the parameters of pressure (dP/dt, -dP/dt) and end diastolic volume in the heart in K.O. mouse. We concluded that the partial deletion of RyR-2 is well compensated. Then, we focused on the Ca^<2+> pump of sarcoplasmic reteiculum (SERCA2a) which plays an important role in the regulation of [Ca^<2+>]i. We overexpressed SERCA 2a (TG) and explored its cardiac functions. In TG, &P/dt and-dP/dt were larger than those in nonTG (NTG). In TG, cardiac hypertrophy was significantly reduced when the heart was loaded with higher pressure. Thus, SERCA2a plays a key role to improve pathophysiological adaptation. We dissected papillary muscles from the left ventricle of TO and measured Ca^<2+> transient(CaT) with aequorin. The peak of CaT was larger than that of NTG. The time courses of CaT in TG were faster than those in NTG. In NTG, isoprenaline increased the peak of CaT and shortened the time course of CaT. However, no significant changes of these parameters were observed in TO. In CO_2 acidosis, contraction was decreased although CaT was increased in NTG. In TO, similar changes were observed but the inhibition of contraction in acidosis was reduced. The recovery of contraction was also better than that in NTG. Thus, SERCA2a plays a pivotal role under pathophysiological condition.
我们建立了Ryanodine受体2型(RyR-2(+/-))基因敲除小鼠,并对心脏功能进行了研究。在Langenforff灌流中,我们没有检测到K.O小鼠心脏的压力参数(dp/dt,-dp/dt)和舒张末容量有任何明显的变化。我们的结论是,RyR-2的部分缺失得到了很好的补偿。然后,我们重点研究了肌浆网钙泵(SERCA2a)在[Ca^<;2+>;]i调节中的重要作用,并对其心脏功能进行了研究。TG组的-P/dt和-dp/dt均大于非TG组(NTG)。在TG组,当心脏负荷较高时,心肌肥厚明显减轻。因此,SERCA2a在改善病理生理适应中起着关键作用。我们解剖左心室乳头肌,用去甲肾上腺素测定钙瞬变(CAT)。CAT的峰值大于NTG。TG组CAT的时间进程快于NTG组。在NTG中,异丙肾上腺素增加了CAT的峰值,缩短了CAT的时间。然而,在TO中,这些参数没有明显的变化。在CO_2酸中毒时,收缩减少,而在NTG时,CAT升高。在TO中,也观察到了类似的变化,但对酸中毒收缩的抑制作用减弱。收缩功能恢复情况也好于NTG组。因此,SERCA2a在病理生理条件下起着关键作用。
项目成果
期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kusakari Y: "The Mechanism of an Increasing in Ca^<2+> Responsiveness by α_1-Adrenergic Stimulation in Rat Ventricular Myocytes."Jpn J Physiol. 52(6). 531-539 (2002)
Kusakari Y:“通过α_1-肾上腺素刺激大鼠心室肌细胞增加Ca ^ 2+ 反应性的机制”。Jpn J Physiol。52(6)(2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kusakari Y: "The mechanism of an increase in Ca^<2+> responsiveness by α_1-adrenergic stimulation in rat ventricular myocytes"Jpn J Physiol. 52(6). 531-539 (2002)
Kusakari Y:“通过α_1-肾上腺素刺激大鼠心室肌细胞的Ca ^ 2+ 反应性增加的机制”Jpn J Physiol.52(6)(2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
草刈洋一郎: "不全心における収縮障害の細胞内メカニズム-SERCA2aを中心として-"日本薬理学雑誌. 123(2). 87-93 (2004)
Yoichiro Kusakari:“衰竭心脏收缩功能障碍的细胞内机制 - 关注 SERCA2a”《日本药理学杂志》123(2) 87-93 (2004)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Asahi M: "Regulation of Sarco(endo)plasmic Reticulum Ca^<2+> Adenosine Trip hosphatase by Phospholamban and Sarcolipin : Implication for Cardiac Hypertrophy and Failure."Trends Cradiovasc Med. 13(4). 152-157 (2003)
Asahi M:“磷酸酶和肌脂蛋白对肌(内)质网 Ca^<2> 腺苷磷酸酶的调节:对心脏肥大和衰竭的影响。”Trends Cradiovasc Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kurihara S: "Measurement of intracellular Ca^<2+> signal in cardiac muscles using aequorin"Japanese Journal Electrocardiology. 21. S-2-3-S-2-14 (2001)
Kurihara S:“使用水母发光蛋白测量心肌中的细胞内Ca ^ 2 信号”,日本电心脏病学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KURIHARA Satoshi其他文献
KURIHARA Satoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KURIHARA Satoshi', 18)}}的其他基金
Proposal of adaptive coordination formation control mechanism for multiagent planning
多智能体规划自适应协调编队控制机制的提出
- 批准号:
23300058 - 财政年份:2011
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Proposal of hierarchy structure emergence mechanism for large scale complex systems
大规模复杂系统层次结构涌现机制的提出
- 批准号:
23650071 - 财政年份:2011
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular mechanisms of an improvement in prognosis in the mouse model of dilated cardiomyopathy treated by inhibition of the RAA system
抑制 RAA 系统治疗扩张型心肌病小鼠模型预后改善的分子机制
- 批准号:
22300130 - 财政年份:2010
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Proposal of top-down controllable multiagent coordination mechanism
自上而下的可控多主体协调机制的提出
- 批准号:
20500133 - 财政年份:2008
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanism of contractile dysfunction and the alteration of intracellular Ca^<2+> handling caused by mutation of cardiac troponin T
心肌肌钙蛋白T突变引起收缩功能障碍及细胞内Ca^2处理改变的分子机制
- 批准号:
19500357 - 财政年份:2007
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of Ca^<2+> uptake by sarcolipin in cardiac sarcoplasmic reticulum.
心脏肌浆网肌磷脂摄取Ca ^ 2 的分子机制。
- 批准号:
16500269 - 财政年份:2004
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research on assessment system of medical dental students' clinical competence before entering clinical clerkship
医学牙科学生进入临床实习前临床能力评价体系研究
- 批准号:
13800002 - 财政年份:2001
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Special Purposes
A Basis Study of Ethnographies in Southwest of China -Mainly Yunnan Area-
西南地区——主要是云南地区——民族志基础研究
- 批准号:
13610368 - 财政年份:2001
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Production of new recombinant aequorin and its physiological application
新型重组水母发光蛋白的制备及其生理应用
- 批准号:
13557004 - 财政年份:2001
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Mechanisms of Active Cross-bridge-dependent Regulation of Ca affinity of Cardiac Troponin
心肌肌钙蛋白 Ca 亲和力的主动跨桥依赖性调节的分子机制
- 批准号:
10470010 - 财政年份:1998
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
相似国自然基金
维持心肌能量代谢稳态对于降低老龄脓毒血症大鼠病死率的意义
- 批准号:30801210
- 批准年份:2008
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
- 批准号:
10749672 - 财政年份:2024
- 资助金额:
$ 2.18万 - 项目类别:
Clarifying Pathophysiology of Atrial Fibrillation by Tissue Multi-Omics Analysis of Atrial Myocardium
通过心房心肌的组织多组学分析阐明心房颤动的病理生理学
- 批准号:
23KJ0378 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Antiarrhythmic mechanisms of chronic vagal nerve stimulation in sympathetic neurons
交感神经元慢性迷走神经刺激的抗心律失常机制
- 批准号:
10635151 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Bioelectric monitoring and neuromodulation of the heart
心脏的生物电监测和神经调节
- 批准号:
10655997 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Intraoperative Pulsed Field Ablation and Lesion Assessment System
术中脉冲场消融和病变评估系统
- 批准号:
10762116 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Catheter-injectable system for local drug delivery after myocardial infarct
用于心肌梗死后局部给药的导管注射系统
- 批准号:
10722614 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
In vivo precision genome editing to correct genetic disease
体内精准基因组编辑以纠正遗传疾病
- 批准号:
10771419 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:














{{item.name}}会员




